Frank Holler, Chairman & CEO
Frank Holler is an active investor and successful entrepreneur. He previously served as President & CEO of Xenon Pharmaceuticals Inc.; President & CEO of ID Biomedical Corporation; and as a founding director of Angiotech Pharmaceuticals.
Jim Heppell, President and Partner
Jim Heppell has acted as a director, officer or advisor to many life science companies. He was previously a corporate finance lawyer with the law firms Russell & DuMoulin and Catalyst Corporate Finance Lawyers (both firms now part of Fasken Martineau).
David Raffa, Fund Manager
David Raffa was a founder and COO of Advantage is now on a one year contract as Fund Manager until December 31, 2012.
Ray Matthews, Vice President & Marketing
Ray Matthews leads Advantage's investors relations efforts. He is a marketing, business development and financing specialist as well as a successful entrepreneur.
